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AbstractIntroduction
Pelvic actinomycosis constitutes 3% of all human actinomycosis infections. It is usually insidious, and is often
mistaken for other conditions such as diverticulitis, abscesses, inflammatory bowel disease and malignant tumors,
presenting a diagnostic challenge pre-operatively; it is identified post-operatively in most cases. Here we present a
case that presented as pelvic malignancy and was diagnosed as pelvic actinomycosis post-operatively.
Case presentation: A 48-year-old Caucasian Turkish woman presented to our clinic with a three-month history of
abdominal pain, weight loss and difficulty in defecation. She had used an intra-uterine device for 16 years,
however it had recently been removed. The rectosigmoidoscopy revealed narrowing of the lumen at 12 cm due to
a mass lesion either in the wall or due to an extrinsic lesion that prevented the passage of the endoscope. On
examination, there was no gynecological pathology. Magnetic resonance imaging showed a mass, measuring 5.5 ×
4 cm attached to the rectum posterior to the uterus. The ureter on that side was dilated. Surgically there was a
pelvic mass adhered to the rectum and uterine adnexes, measuring 10 × 12 cm. It originated from uterine
adnexes, particularly ones from the left side and formed a conglomerated mass with the uterus and nearby organs;
the left ureter was also dilated due to the pelvic mass. Because of concomitant tubal abscess formation and
difficulty in dissection planes, total abdominal hysterectomy and bilateral salphingo-oophorectomy was performed
(our patient was 48 years old and had completed her childbearing period). The cytology revealed inflammatory
cells with aggregates of Actinomyces. Penicillin therapy was given for six months without any complication.
Conclusions: Pelvic actinomycosis should always be considered in patients with a pelvic mass especially in ones
using intra-uterine devices, and who have a history of appendectomy, tonsillectomy or dental infection. Surgeons
should be aware of this infection in order to avoid excessive surgical procedures.
Introduction
Actinomycosis is a chronic granulomatous disease caused
by any of several anaerobic organisms from the genus
Actinomyces. Abdominal disease is usually insidious and
is often mistaken for other conditions such as diverticuli-
tis, abscesses, inflammatory bowel disease and malignant
tumor, presenting a diagnostic challenge pre-operatively
[1]; it is identified post-operatively in most cases [1].
Here, we present a case considered as pelvic malignancy
and diagnosed as pelvic actinomycosis post-operatively.
Case presentation
A 48-year-old Caucasian Turkish woman presented to
our clinic with a three-month history of abdominal pain,
weight loss and difficulty in defecation. She had a
16-year history of intra-uterine device (IUD) use, which
had recently been removed. On physical examination,
the abdomen was normal, without any mass; on rectal
digital examination, there was a rigid, immobile mass in
the anterior part of the rectum. Laboratory evaluation
showed a white blood cell count of 12,400. A rectosig-
moidoscopy revealed narrowing of the lumen at 12 cm
due to a mass lesion either in the wall or due to an
extrinsic lesion that prevented the passage of the endo-
scope. Histopathological diagnosis of tissue samples
taken from the mucosa of the narrowed lumen was
inflammatory pattern. On gynecological examination
and endovaginal ultrasound there was no gynecologic
pathology. Magnetic resonance imaging (MRI) showed a
mass, measuring 5.5 × 4 cm, attached to the rectum* Correspondence: draksimsek@yahoo.com.tr
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posterior to the uterus. The ureter on that side was
dilated (Figure 1).
We performed an exploratory laparotomy, which
showed a pelvic mass adhered to the rectum and uterine
adnexes, measuring 10 × 12 cm. It originated from uter-
ine adnexes particularly from the left side and formed a
conglomerated mass with the uterus and nearby organs;
the left ureter was also dilated due to the pelvic mass.
Because of concomitant tubal abscess formation and
difficulty in dissection planes, total abdominal hysterect-
omy and bilateral salphingo-oophorectomy was per-
formed (our patient was 48-year-old and had completed
her childbearing period).
Her post-operative recovery was normal. Cytology
revealed inflammatory cells with aggregates of Actino-
myces. Penicillin therapy was given for six months with-
out any complication. She is well and has gained weight
after one year.
Discussion
Actinomycosis is a chronic granulomatous disease caused
by any of several anaerobic organisms from the genus
Actinomyces. Although previously thought to be a fungal
infection, these organisms are Gram-positive, filamentous
bacteria. Disease in humans is most commonly caused by
A. israelii [2]. These organisms are not considered parti-
cularly virulent pathogens, but rather as opportunistic
ones, because infection usually occurs only after disrup-
tion of the mucous membranes. The disease spreads by
direct extension into surrounding tissues regardless of
tissue planes through the formation of sinus tracts that
can lead directly to the skin. Typically sulfur granules can
drain from these tracts.
Actinomycosis is traditionally divided into three forms:
cervicofacial, thoracic, and abdominogenital. The most
frequent site of human infection is the cervicofacial
area, accounting for about 40 to 50% of cases. Approxi-
mately, 15% of actinomycosis occurs in the thorax [2,3].
Twenty percent of actinomycotic infections occur in the
abdomen and pelvis [3,4]. Pelvic actinomycosis constitu-
tes 3% of all human actinomycotic infections.
Abdominal disease usually results from clinical or sub-
clinical disruption of bowel mucosa. It often occurs as a
firm mass that appears fixed to the surrounding tissue
and can be mistaken for a tumor [4-6]. Abdominal sur-
gery, ruptured viscus, tubo-ovarian abscess and IUDs
are recognized risk factors for abdominal and pelvic
actinomycosis [7]. A. israelii infects 1.65% to 11.6% of
IUD users, and infection is more common in women
who have had an IUD use in situ longer than four years.
In females, Actinomyces is thought to be induced by
oro-genital contact [8].
When pelvic actinomycosis occurs, it usually causes
endometritis, salpingo-oophoritis, or tubo-ovarian abscess
and a mass in the adnexa might be palpable, suggesting a
pelvic malignancy [6,9,10]. Ultimately, extension to
the abdominal wall or deep pelvic structures can occur.
Primary bowel involvement is rare, although it has
increased in frequency over recent years. The most
common sites of the disease are the transverse colon and
the cecum with the appendix [11,12].
Diagnosis of actinomycosis can be difficult because of
the insidious nature of the infection. Usually, diagnosis
is impossible pre-operatively, even after fine-needle
aspiration [13]. The finding of sulfur granules from any
other site than the tonsils is considered pathogonomonic
[14]. Computed tomography- or ultrasound-guided
biopsy can be used to obtain material for diagnosis.
Occasionally, as in our patient, surgery may be required.
Penicillin is the drug of choice; resistance is rare. High
doses must be given for prolonged courses. In those who
are allergic to penicillin, options include tetracyclines,
erythromycin, doxycycline and clindamycin. However,
response to tetracyclines and ciprofloxacin is poor and a
beta lactam antibiotic combined with a beta lactamase
inhibitor, should be the first choice [15]. Parenteral ther-
apy might be required for severe infection before chan-
ging to the oral route. Generally, the disease is treated
until there is evidence of complete resolution. Surgery is
occasionally required to drain abscesses, but because acti-
nomycotic infection does not follow tissue planes, sur-
gery can be complicated and, if possible, should be
delayed at least until after a course of antibiotic use.
Figure 1 Abdominal MRI shows a 5.5 × 4 cm mass near the
rectum posterior to the uterus.
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Conclusions
Pelvic actinomycosis should always be considered in
patients with pelvic mass especially in those using IUD,
and who have a history of appendectomy, tonsillectomy
or dental infection. Antimicrobial therapy should be
initiated following surgery. Surgeons should be aware of
this infection in order to avoid excessive surgical
procedures.
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